<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Therapeutic <z:hpo ids='HP_0002045'>hypothermia</z:hpo> is currently used to reduce neurological ischemic damage in postcardiac arrest patients </plain></SENT>
<SENT sid="1" pm="."><plain>Nevertheless, it has been associated with relevant side effects such as <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e>, <z:mp ids='MP_0001914'>bleeding</z:mp>, <z:hpo ids='HP_0002615'>hypotension</z:hpo> and <z:hpo ids='HP_0002153'>hyperkalemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Although <z:hpo ids='HP_0002045'>hypothermia</z:hpo>-induced <z:e sem="disease" ids="C0010073" disease_type="Disease or Syndrome" abbrv="">coronary spasm</z:e> is rare, its occurrence needs to be considered attentively as it adds a high risk of <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> and <z:hpo ids='HP_0001695'>cardiac arrest</z:hpo> in patients with already-existing critical heart conditions </plain></SENT>
</text></document>